These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats. Thorsen LB, Eskildsen-Helmond Y, Zibrandtsen H, Stasch JP, Simonsen U, Laursen BE. Eur J Pharmacol; 2010 Nov 25; 647(1-3):147-54. PubMed ID: 20828552 [Abstract] [Full Text] [Related]
7. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide. Zheng X, Ying L, Liu J, Dou D, He Q, Leung SW, Man RY, Vanhoutte PM, Gao Y. Cardiovasc Res; 2011 Jun 01; 90(3):565-72. PubMed ID: 21248051 [Abstract] [Full Text] [Related]
8. Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide. Ye L, Liu J, Liu H, Ying L, Dou D, Chen Z, Xu X, Raj JU, Gao Y. Pflugers Arch; 2013 Feb 01; 465(2):333-41. PubMed ID: 23143201 [Abstract] [Full Text] [Related]
9. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Chester M, Tourneux P, Seedorf G, Grover TR, Gien J, Abman SH. Am J Physiol Lung Cell Mol Physiol; 2009 Aug 01; 297(2):L318-25. PubMed ID: 19465519 [Abstract] [Full Text] [Related]
10. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats. Deruelle P, Balasubramaniam V, Kunig AM, Seedorf GJ, Markham NE, Abman SH. Biol Neonate; 2006 Aug 01; 90(2):135-44. PubMed ID: 16582538 [Abstract] [Full Text] [Related]
14. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. Wen HC, Chuu CP, Chen CY, Shiah SG, Kung HJ, King KL, Su LC, Chang SC, Chang CH. PLoS One; 2015 Aug 01; 10(4):e0125518. PubMed ID: 25928539 [Abstract] [Full Text] [Related]
15. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. Lang M, Kojonazarov B, Tian X, Kalymbetov A, Weissmann N, Grimminger F, Kretschmer A, Stasch JP, Seeger W, Ghofrani HA, Schermuly RT. PLoS One; 2012 Aug 01; 7(8):e43433. PubMed ID: 22912874 [Abstract] [Full Text] [Related]
16. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch JP, Gnoth MJ, Seeger W, Grimminger F, Schermuly RT. Circulation; 2006 Jan 17; 113(2):286-95. PubMed ID: 16391154 [Abstract] [Full Text] [Related]
17. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease. Potoka KP, Wood KC, Baust JJ, Bueno M, Hahn SA, Vanderpool RR, Bachman T, Mallampalli GM, Osei-Hwedieh DO, Schrott V, Sun B, Bullock GC, Becker-Pelster EM, Wittwer M, Stampfuss J, Mathar I, Stasch JP, Truebel H, Sandner P, Mora AL, Straub AC, Gladwin MT. Am J Respir Cell Mol Biol; 2018 May 17; 58(5):636-647. PubMed ID: 29268036 [Abstract] [Full Text] [Related]
18. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Brandes RP, Kim D, Schmitz-Winnenthal FH, Amidi M, Gödecke A, Mülsch A, Busse R. Hypertension; 2000 Jan 17; 35(1 Pt 2):231-6. PubMed ID: 10642303 [Abstract] [Full Text] [Related]